A company can only ride the tide if it stays in business. And it can only stay in business if it has the funds to do so.
Virax's cash position is so weak that even its auditors have expressed concern as to the company's ability to continue as a going concern.
All the positive sentiment in the world regarding immunotherapy counts for nought if you have no cash in the bank.
may 1st dndn decision, page-14
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)